DV1 (TFA)

DV1 TFA is a selective antagonist for CXC chemokine receptor 4 (CXCR4) . DV1 TFA exhibits antiviral activity by blocking HIV-1 entry through the CXCR4 co-receptor[1].

C108H170N34O26S2.xC2HF3O2

O=C([C@H](N)CC(C)C)NCC(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N1[C@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(NCC(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N2[C@H](C(N[C@@H](C(N3[C@@H](C(N)=O)CCC3)=O)CC(C)C)=O)CCC2)=O)CCCNC(N)=N)=O)CCCCN)=O)CCC(N)=O)=O)CC4=CC=C(O)C=C4)=O)=O)CC(C)C)=O)CS)=O)CS)=O)CCCCN)=O)CC(O)=O)=O)CCC1)=O)CCCNC(N)=N)=O)CC5=CNC=N5)=O)CC6=CNC7=CC=CC=C67)=O)CO)=O)C)=O.OC(C(F)(F)F)=O.[x]

CXCR; HIV

98.53

DMSO : 100 mg/mL (ultrasonic)

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

Blue Ice